Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Microb Cell Fact ; 16(1): 91, 2017 May 23.
Artigo em Inglês | MEDLINE | ID: mdl-28535808

RESUMO

BACKGROUND: Levan has been traditionally produced from microorganism. However, there is a continuous effort in looking for new strains that improve levan production yield and uses alternative sugar sources for growth. Despite having a wide range of data about levan yield, there are not papers which allow controlling molecular weight, and that plays an essential role for further applications. RESULTS: The effect of the sucrose concentration on levan yield (and its molecular weight) from Bacillus atrophaeus and Acinetobacter nectaris (Gram positive and Gram negative respectively) was studied in this work. It was found that A. nectaris growth (from 3 to 1.5 g L-1 in 40 h) and its levan production (from 3 to 1.5 g L-1) decreases by increasing sucrose concentration (best results at a concentration of 120 g L-1) whereas B. atrophaeus growth (3.5 g L-1 in 30 h) and its levan production (also 3.5 g L-1) were not affected by modifying that parameter. Levan molecular weight from A. nectaris decreases by increasing sucrose concentration (from 8000 to 2000 kDa) whereas levan molecular weight from B. Atrophaeus remains always around 50 kDa. By performing a kinetic study, it was shown that A. nectaris growth follows a substrate-inhibition model, whereas Monod equation provided a good fit for B. atrophaeus growth. Finally, wastes from orange juice industry were used as a medium culture to cultivate those microorganism, obtaining good results with B. atrophaeus (growth 3 g L-1 in 30 h). CONCLUSIONS: Levan production kinetics was determined and compared between different bacteria types.


Assuntos
Antineoplásicos/análise , Bactérias/metabolismo , Frutanos/biossíntese , Sacarose/metabolismo , Acinetobacter/efeitos dos fármacos , Acinetobacter/crescimento & desenvolvimento , Acinetobacter/metabolismo , Bacillus/efeitos dos fármacos , Bacillus/crescimento & desenvolvimento , Bacillus/metabolismo , Bactérias/efeitos dos fármacos , Bactérias/crescimento & desenvolvimento , Citrus sinensis , Meios de Cultura/química , Fermentação , Sucos de Frutas e Vegetais , Peso Molecular , Sacarose/farmacologia
2.
Carbohydr Polym ; 160: 26-33, 2017 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-28115097

RESUMO

New drug delivery systems (DDSs) with levan or its carboxymethylated form, as carriers, and 5-fluorouracil as a drug, are produced in this work. Levan is obtained after cultivating A. nectaris and polymer nanoparticles are created in water by a self-assembled process. The effect of pH and the ionic strength on polymer nanoparticles aggregation is studied. Basic pHs produces a particle size between 300 and 400nm with a Z-potential around -20mV because a basic medium promotes repulsion forces. DDSs of 300-400nm and a Z-potential about -25mV are prepared by taking advantage of the amphiphilic properties of the levan. The drug is bound to either levan or carboxymethyllevan surfaces by electrostatic interactions, obtaining the best results at basic pHs. 45-70% of the drug is released from the levan in 23h depending on the pH preparation, whereas only a low percentage of the drug is released from the carboxymethyllevan.


Assuntos
Sistemas de Liberação de Medicamentos , Fluoruracila/química , Frutanos/química , Frutose/química , Nanopartículas , Portadores de Fármacos , Liberação Controlada de Fármacos , Estabilidade de Medicamentos , Tamanho da Partícula , Polímeros
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA